Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community-wide versus school-based albendazole deworming for soil-transmitted helminth reinfection in Vietnamese schoolchildren
ACTRN12619000309189Phase 4Not yet recruiting
- Sponsor
- University of New South Wales
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albendazole in Soil-Transmitted Helminthiases (STH), hookworm infection, ascariasis and 1 more (2 arms), sponsored by University of New South Wales. Primary endpoint: Prevalence of hookworm infection. Planned start Nov 2019; status: not yet recruiting.
02
Drugs
albendazole
03
Conditions
Soil-Transmitted Helminthiases (STH)hookworm infectionascariasistrichuriasis
Beyond the preview
Go deeper on ACTRN12619000309189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000309189.